References
- MMWR Morb Mortal Wkly Rep. 2007; 56: 701–705
- Matorras R, García-Perea A, Omeñaca F, Diez-Enciso M, Madero R, Usandizaga J A. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. Eur J Obstet Gynecol Reprod Biol 1991; 40: 57–62
- Tuppurainen N, Hallman M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol 1989; 73: 583–587
- Boyer K M, Gotoff S P. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986; 314: 1665–1669
- Schrag S J, Zell E R, Lynfield R. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002; 347: 233–239
- Schrag S J, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep Morb and Mortal Wkly Rep 2002; 51(RR-11)1–22
- Heelan J S, Hasenbein M E, McAdam A J. Resistance of group B Streptococcus to selected antibiotics, including erythromycin and clindamycin. J Clin Microbiol 2004; 42: 1263–1264
- Edwards R K, Clark P, Duff P. Intrapartum antibiotic prophylaxis 2: positive predictive value of antenatal group B Streptococci cultures and antibiotic susceptibility of clinical isolates. Obstet Gynecol 2002; 100: 540–544
- Arisoy A S, Altinişik B, Tünger Ö, Kurutepe S, Ispahi C. Maternal carriage and antimicrobial resistance profile of group B Streptococcus. Infection 2003; 31: 244–246
- Rouse D J, Andrews W W, Lin F C, Mott C W, Ware J C, Philips J B. Antibiotic susceptibility profile of group B Streptococcus acquired vertically. Obstet Gynecol 1998; 92: 931–934
- Liu J W, Wu J J, Ko W C, Chuang Y C. Clinical characteristics and antimicrobial susceptibility of invasive group B streptococcal infection in nonpregnant adults in Taiwan. J Formos Med Assoc 1997; 96: 628–633
- Fernandez M, Hickman M E, Baker C J. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother 1998; 42: 1517–1519
- NCCLS. Performance standards for antimicrobial susceptibility testing. NCCLS, Wayne, Pa. 2002; M100–S12
- Alexander G R, Kotelchuck M. Quantifying the adequacy of prenatal care. Public Health Rep 1996; 111: 408–419
- Stiller R J, Padilla L, Choudhary R, Tinghitella T, Laifer S. Group B streptococcal antibiotic resistance patterns in pregnant women. Connecticut Med 2003; 67: 323–326
- Manning S D, Foxman B, Pierson C L, Tallman P, Baker C J, Pearlman M D. Correlates of antibiotic-resistant group B Streptococcus isolated from pregnant women. Obstet Gynecol 2003; 101: 74–79
- Simoes J A, Aroutcheva A A, Heimler I, Faro S. Antibiotic resistance patterns of group B streptococcal clinical isolates. Infect Dis Obstet Gynecol 2004; 12: 1–8
- Campbell J R, Hillier S L, Krohn M A, Ferrieri P, Zaleznik D F, Baker C J. Group B streptococcal colonization and serotypespecific immunity in pregnant women at delivery. Obstet Gynecol 2000; 96: 498–503
- Meyn L A, Moore D M, Hillier S L, Krohn M A. Association of sexual activity with colonization and vaginal acquisition of group B Streptococcus in nonpregnant women. Am J Epidemiol 2002; 155: 949–957
- Hsueh P R, Teng L J, Lee C M, Huang W K. SMART Program 2001 Data. Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data. Antimicrob Agents Chemother 2003; 47: 2152–2157
- Chen K T, Huard R C, Della_latta P, Saiman L. Pevalence of Methicillin-sensitive and methicillin-resistant Staphylococcus aureus in Pregnant Women. Obstet Gynecol 2006; 108: 482–487